Please wait while the formulary information is being retrieved.
Drug overview for INVELTYS (loteprednol etabonate):
Generic name: loteprednol etabonate (LOE-te-PRED-nol)
Drug class: Ophthalmic Steroids
Therapeutic class: Ophthalmic Agents
Loteprednol etabonate is a synthetic nonfluorinated corticosteroid.
No enhanced Uses information available for this drug.
Generic name: loteprednol etabonate (LOE-te-PRED-nol)
Drug class: Ophthalmic Steroids
Therapeutic class: Ophthalmic Agents
Loteprednol etabonate is a synthetic nonfluorinated corticosteroid.
No enhanced Uses information available for this drug.
DRUG IMAGES
INVELTYS 1% EYE DROP
The following indications for INVELTYS (loteprednol etabonate) have been approved by the FDA:
Indications:
Post-op ocular inflammation
Postoperative ocular pain
Professional Synonyms:
Post-op ocular pain
Postoperative eye pain
Postoperative ocular inflammation
Postoperative ophthalmic inflammation
Indications:
Post-op ocular inflammation
Postoperative ocular pain
Professional Synonyms:
Post-op ocular pain
Postoperative eye pain
Postoperative ocular inflammation
Postoperative ophthalmic inflammation
The following dosing information is available for INVELTYS (loteprednol etabonate):
Safety and efficacy of ophthalmic suspensions containing loteprednol etabonate alone or in fixed combination with tobramycin have not been established in children younger than 18 years of age.
Loteprednol etabonate alone or in fixed combination with tobramycin is applied topically to the eye as an ophthalmic suspension. The suspension should be shaken vigorously prior to use. Care should be taken to avoid contamination of the container.
| DRUG LABEL | DOSING TYPE | DOSING INSTRUCTIONS |
|---|---|---|
| INVELTYS 1% EYE DROP | Maintenance | Adults instill 1 - 2 drops into affected eye(s) by ophthalmic route 2 times per day for 14 days |
No generic dosing information available.
The following drug interaction information is available for INVELTYS (loteprednol etabonate):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for INVELTYS (loteprednol etabonate):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 4 contraindications.
Absolute contraindication.
| Contraindication List |
|---|
| Fungal infection of eye |
| Herpes simplex dendritic keratitis |
| Tuberculosis of the eye |
| Vaccinia virus keratitis |
There are 2 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Glaucoma |
| Ocular hypertension |
There are 0 moderate contraindications.
The following adverse reaction information is available for INVELTYS (loteprednol etabonate):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 12 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Chemosis |
Keratoconjunctivitis Uveitis |
| Rare/Very Rare |
|---|
|
Bacterial eye infection Cataracts Fungal infection of eye Glaucoma Globe perforation Impaired wound healing Ocular infection Posterior capsule opacification Viral ocular infection |
There are 20 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Anterior chamber inflammation Blurred vision Conjunctival hyperemia Corneal edema Dry eye Eye tearing Headache disorder Ocular itching Ocular pain Ocular redness Pharyngitis Photophobia Rhinitis Visual changes |
Conjunctivitis Eyelid erythema Ocular discharge Ocular hypertension Ocular irritation |
| Rare/Very Rare |
|---|
|
Foreign body sensation of eye |
The following precautions are available for INVELTYS (loteprednol etabonate):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for INVELTYS (loteprednol etabonate):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for INVELTYS (loteprednol etabonate)'s list of indications:
| Post-op ocular inflammation | |
| H57.8 | Other specified disorders of eye and adnexa |
| Postoperative ocular pain | |
| H57.1 | Ocular pain |
| H57.10 | Ocular pain, unspecified eye |
| H57.11 | Ocular pain, right eye |
| H57.12 | Ocular pain, left eye |
| H57.13 | Ocular pain, bilateral |
Formulary Reference Tool